After developing its data pooling service for Canadian banks, CanDeal has now launched a data and analytics unit, DNA, for OTC derivatives pricing. We talked to executive vice president of DNA, Andre Craig, about results so far and how repo is expected to fit in.
This content requires a Finadium subscription. Articles with an unlocked symbol can be accessed with free registration. Log in or create a free account by signing up here..
